Farmer Brothers Coffee Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
Globenewswire· 2025-09-12 04:15
Fiscal year 2025 gross margin increase of 420 basis points year-over-year to 43.5% Reported full year net loss of $14.5 million, increase in year-over-year adjusted EBITDA1 of more than $14 million Fiscal 2025 net sales of $342.3 million FORT WORTH, Texas, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Farmer Brothers Coffee Co. (NASDAQ: FARM), a leading roaster, wholesaler and distributor of coffee, tea and allied products, announced today its fourth quarter and full year fiscal 2025 financial results for the period e ...
Team, Inc. Announces Private Placement of Preferred Stock
Globenewswire· 2025-09-12 04:15
Reduces Leverage and Provides Enhanced Financial Flexibility SUGAR LAND, Texas, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global, leading provider of specialty industrial services offering clients access to a full suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services, today announced that it has successfully closed on a private placement of preferred stock and warrants to affiliates of Stellex Capital Management L ...
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
Globenewswire· 2025-09-12 04:15
Southlake, TX, Sept. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart disease, today announced its financial results for the first quarter of fiscal 2026 ended July 31, 2025 (“FQ1 2026”) and provided a business update highlighting continued progress. First Quarter and Recent Highlights HeartSciences has made substantial prog ...
Marimaca Copper Announces Closing of A$80,000,000 Placement
Globenewswire· 2025-09-12 04:15
Not for release to U.S. wire services or for distribution in the United States VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Marimaca Copper Corp. (TSX: MARI) (ASX: MC2) (“Marimaca” or the “Company”) is pleased to announce the closing of the previously announced brokered placement in Australia and select other jurisdictions, excluding Canada (the “Placement”). Pursuant to the closing of the Placement, the Company issued 8,247,423 Chess Depositary Interests (“CDI”) each at a price of A$9.70 ...
K. Hovnanian Enterprises, Inc. Prices Offering of $450 Million of 8.000% Senior Notes Due 2031 and $450 Million of 8.375% Senior Notes Due 2033
Globenewswire· 2025-09-12 04:15
MATAWAN, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Hovnanian Enterprises, Inc. (NYSE: HOV) (the “Company”) announced today that its wholly owned subsidiary, K. Hovnanian Enterprises, Inc. (“K. Hovnanian”), priced an offering of $450 million aggregate principal amount of 8.000% Senior Notes due 2031 and $450 million aggregate principal amount of 8.375% Senior Notes due 2033 in a private placement (collectively, the “Notes”). The Notes will be guaranteed by the Company and substantially all of its subsidiaries ...
BRT Apartments Corp. Declares Third Quarter 2025 Dividend and Announces Management Appointments
Globenewswire· 2025-09-12 04:10
GREAT NECK, New York, Sept. 11, 2025 (GLOBE NEWSWIRE) -- BRT APARTMENTS CORP. (NYSE: BRT) announced today that its Board of Directors declared a quarterly dividend of $0.25 per share. The dividend is payable October 6, 2025, to stockholders of record at the close of business on September 24, 2025. Additionally, the Company announces the appointment of Matthew Gibbons and Isaac Kalish as chief accounting officer and chief financial officer, respectively. Mr. Gibbons' appointment is effective immediately, and ...
NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private Placement Closing
Globenewswire· 2025-09-12 04:10
TORONTO and HAIFA, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to provide the following corporate updates. Israeli Patent Grant Expands Global Jurisdiction The Israel Patent Office has granted the Company’s Patent, entitled “Production of Extracellular Vesicles from Stem Cells.” This grant aligns with NurExone’s recently ...
UTime Limited Reaffirms Current Leadership and Board Composition Following Issuance of Unauthorized Press Release
Globenewswire· 2025-09-12 04:07
SHENZHEN, China, Sept. 11, 2025 (GLOBE NEWSWIRE) -- UTime Limited (the "Company" or “Utime”) (NASDAQ: WTO), a mobile device manufacturer and technology company, today issued a statement regarding misinformation the Company believes is being put into the market by a former employee and to clarify that UTime’s management and board composition remains unchanged following the unauthorized publication of two press releases put out overnight. On September 11, 2025, two fraudulent press releases were published – o ...
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Globenewswire· 2025-09-12 04:07
NEW YORK and WALTHAM, Mass., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases (“Dianthus” or the “Company”), today announced that it closed its previously announced underwritten public offering of 7,627,879 shares of its common stock, including the full exercise by the underwriters of their option to purchase an additional 1,1 ...
Frequency Electronics, Inc. Announces First Quarter Fiscal Year 2026 Financial Results
Globenewswire· 2025-09-12 04:05
• Announces $20 million share repurchase authorization MITCHEL FIELD, N.Y., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM) is pleased to announce its financial results for the first quarter of fiscal year 2026. Revenue for the first quarter ended July 31, 2025, was approximately $13.8 million, a decrease from the $15.1 million reported for the same period of fiscal year 2025. Operating income for the first quarter of fiscal year 2026 was $0.4 million, a ...